TrialBMC cancer2019

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.

Uanderson Resende et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.